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Brain tissue is highly dynamic in terms of electrical activity and energy demand.
Relevant energy metabolites have turnover times ranging from milliseconds to seconds
and are rapidly exchanged between cells and within cells. Until recently these fast
metabolic events were inaccessible, because standard isotopic techniques require use
of populations of cells and/or involve integration times of tens of minutes. Thanks
to fluorescent probes and recently available genetically-encoded optical nanosensors,
this Technology Report shows how it is now possible to monitor the concentration of
metabolites in real-time and in single cells. In combination with ad hoc inhibitor-stop
protocols, these probes have revealed a key role for K+ in the acute stimulation of
astrocytic glycolysis by synaptic activity. They have also permitted detection of the
Warburg effect in single cancer cells. Genetically-encoded nanosensors currently exist for
glucose, lactate, NADH and ATP, and it is envisaged that other metabolite nanosensors
will soon be available. These optical tools together with improved expression systems and
in vivo imaging, herald an exciting era of single-cell metabolic analysis.
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INTRODUCTION
It is hard to overestimate the importance of resolution. In the
absence of sufficient temporal resolution transient events go
undetected. Without enough spatial resolution, opposite changes
in neighboring compartments may cancel out. Classic biochem-
istry mapped metabolic pathways and characterized the behavior
of purified enzymes in test tubes. Decades before cell sorting,
enzymes had to be extracted from whole brain homogenates.
Metabolites were measured, again in whole tissue extracts, and
a handful of enzymes thought to catalyze far-from-equilibrium
reactions were deemed to control flux. With the introduction
of radioisotopes in research during the 1950s and non-invasive
techniques for their detection, particularly PET and NMRS, con-
centrations and fluxes could be estimated in living humans, thus
permitting biochemical investigation of brain disease.Meanwhile,
progress in molecular biology, immunohistochemistry, and the
introduction of cell cultures, revealed previously unsuspected
complexities, with numerous isoforms for metabolic enzymes
and transporters plus cell-specific post-translational modifica-
tions. At present, it is evident that neurons and glial cells differ
metabolically as much as they differ functionally, but little is
known regarding subtypes of neurons and astrocytes and their
interaction with oligodendrocytes (Funfschilling et al., 2012; Lee
et al., 2012). Of clinical importance are regional variations in
metabolism across the brain that may help to explain susceptibil-
ity to neurodegeneration (Vaishnavi et al., 2010; Vlassenko et al.,
2010; Bero et al., 2011).
Over the last decade, fluorescence microscopy-based tech-
niques with high spatiotemporal resolution have been introduced
for the study of energy metabolism in cultured cells and in brain
tissue slices. Genetically-encoded sensors are becoming available
and it is now possible to measure, glucose, lactate, NADH, and
ATP in individual cells with sub-second resolution. The present
work describes how some of these sensors may be used in combi-
nation with transport inhibitors, to quantify metabolic flux and
investigate the regulation of astrocytic glycolysis in response to
neuronal activity.
HOW LOCAL AND HOW FAST IS BRAIN METABOLISM?
The average rate of glucose utilization in human gray matter
has been estimated at 8.8μM/s (Huang et al., 1980; Gjedde and
Diemer, 1983), ten times higher than the body’s average. With
this value and the known stoichiometry of the glucose oxidation
(C6H12O6 + 6O2 → 6CO2 + 6H2O) and coupled reactions, it
is possible to obtain an estimate of flux at different points in the
metabolic chain. As the glucose molecule proceeds through gly-
colysis and the Krebs cycle, its free energy is split into smaller
packets and the molar flux rises, reaching a maximum at ATP,
with 31 molecules produced for each glucose molecule consumed
(Figure 1). In addition to flux, metabolite dynamics are deter-
mined by concentration, so that the smaller the concentration,
the larger the impact of a given flux on the metabolite pool. The
ratio between concentration and flux is known as the turnover
time and is a useful parameter of how dynamic a metabolite is.
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The turnover time can be thought of as the time that a metabo-
lite pool would last if production were to stop while consumption
remained constant. As shown in Table 1, brain tissue glucose and
lactate have turnover times in the order of 2min whereas ATP and
oxygen have turnover times of a few seconds, whereas for NADH
it is just 7ms. The turnover time reflect sensitivity of a given
FIGURE 1 | Stoichiometry of glucose oxidation. The schematic
represents the oxidation of glucose to CO2, where the width of the arrows
is proportional to flux. Cytosolic NADH is assumed to transfer its electrons
to mitochondria through both the malate-aspartate shuttle (rendering 3
ATPs per NADH) and the glycerol phosphate shuttle (rendering 2 ATPs per
NADH).
metabolite pool to flux perturbation. According to the simulation
shown in Figure 2, a 100% increase in the rate of consumption
would reduce the respective brain pools with a half time of about
1min for glucose and lactate, 0.3 and 1.5 s for O2 and ATP and
5ms for NADH. Taken in combination with the diffusion coeffi-
cient, the turnover time also helps to reveal how local a metabolite
may be if its diffusion were not restricted by membranes. For
instance, during its turnover time, the average glucose or lactate
molecule can diffuse several hundreds of micrometeres along the
cytosol of a neuron, roughly the diameter of a cortical column or
a cortical barrel, whereas variations in cytosolic NADH in a den-
drite will not be sensed by its soma located just a few micrometers
away (Table 1).
The above considerations help to establish a priori the min-
imum spatial and temporal resolutions required to order to
characterize metabolism. Glucose and lactate dynamics have to be
sampled in seconds, whereas monitoring ATP and O2 may need
techniques that resolve hundreds of milliseconds. To avoid miss-
ing NADH fluctuations, millisecond sampling will be required.
In terms of size, monitoring cytosolic glucose, lactate, O2 or
ATP demand single-cell resolution, whereas cytosolic NADH and
metabolites inside small membrane compartments such as mito-
chondria demand sub-cellular resolution. One may think that
even higher resolution may be needed to characterize the imme-
diate neighborhood of metabolic enzymes and transporters, but
this is not the case. Glucose, lactate, O2, ATP, and any other
molecules present at micromolar levels or higher are not expected
to form microdomains or nanodomains, because the build up or
Table 1 | Dynamics of selected metabolites in brain tissue.
Metabolite Glucose Lactate plus pyruvate ATP O2 NADH
Stoichiometry* 1 2 31 6 2
Concentration (μM) 1000a 2000b 1250c 30d 0.13e
Fluxf (μM/s) 8.8 17.6 273 53 17.6
Turnover timeg (s) 114 114 4.6 0.6 0.007
Diffusion coefficient (D) (μm2/s) 500h 130i 500j 2000k 500l
Average distance traveled over 1
and 10 turnover timesm (μm)
585 and 1849 298 and 943 117 and 371 85 and 268 5 and 14
Generation of nanodomains No No No No Yes
*Whole tissue stoichiometry is given for glucose, lactate/pyruvate, ATP and oxygen, while cytosolic stoichiometry is given for NADH.
aHuman brain tissue (Barros et al., 2007).
bHuman brain tissue (Dienel and Cruz, 2004).
cHeLa cells, MIN6 cells, and COSM6 cells (Zamaraeva et al., 2005) and references therein.
d Human brain tissue (Buxton, 2010).
eCOS7 cells (Zhang et al., 2002).
f The glucose flux was calculated using non-invasive measurements in human gray matter (Huang et al., 1980) and the glucose distribution volume (Gjedde and
Diemer, 1983). The flux of the other metabolites was calculated as the product of the glucose flux and the respective stoichiometry. For NADH the cytosolic flux is
given.
gTurnover time is concentration divided by flux.
hIsotopic deoxyglucose in rat vagus nerve (Vega et al., 2003).
i NMRS in rat brain tissue (Pfeuffer et al., 2000).
j NMRS in rat skeletal muscle (de Graaf et al., 2000).
kOxygen electrode measurements in rat brain tissue (Baumgartl and Lubbers, 1983).
l Assumed to be equal to that of ATP.
mEstimated assuming Brownian diffusion according to the Einstein’s equation in three dimensions (distance2 = 6 × D × turnover time).
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FIGURE 2 | Simulation of the response of metabolites to an instant
rise in consumption. The dynamics of each metabolite were simulated
independently using the concentration and steady-state flux in Table 1 and
the differential equation: d metabolite/dt = production–metabolite × C,
where C is the rate constant of consumption. At time zero, C was
increased by 100% while production was kept constant, resulting in a 50%
decrease in the size of the pool. The speed at which the new steady-state
is reached varies dramatically between different metabolites. The inset
shows the same data over an extended timescale. The differential equation
was solved by numerical simulation using Madonna software.
depletion of metabolites in the immediate vicinity of the proteins
handling these molecules is negligible compared to the powerful
mixing effect of diffusion in short distances (Barros andMartinez,
2007; Martinez et al., 2010). For these abundant molecules, the
cytosol within an astrocyte or a neuronal soma is expected to
behave as a well-mixed compartment. NADH is different, because
its cytosolic concentration is very low. For example, considering
a cytosolic NADH of 130 nM (u), a diffusion coefficient (D) of
500μm2 s−1 (Table 1), and that a single lactate dehydrogenase
enzyme (LDH) produces or consumes lactate at a rate of 260 s−1
(q, Barros and Martinez, 2007), the relative amplitude (AMP) of
the local NADH nanodomain may be estimated using the equa-
tion AMP = 1 ± q/(u × D × a), where a is the radius of the
catalytic site (Martinez et al., 2010). According to this formula
and assuming a radius of 0.5 nm (Barros and Martinez, 2007),
LDH is predicted to create a local nanodomain in which the con-
centration of NADH is twice that of the bulk cytosolic NADH
when the enzyme is consuming lactate, whereas LDH should
deplete its vicinity of NADH when the enzyme is producing lac-
tate. Thus, an accurate characterization of NADH dynamics will
require nanometer resolution.
FAST GLUCOSE DYNAMICS MEASURED WITH
FLUORESCENT GLUCOSE ANALOGS
2-deoxyglucose is a glucose analog that is transported into cells by
the GLUT glucose transporters and then phosphorylated by hex-
okinase, but is not metabolized further to any significant extent.
Detected in cultured cells by scintillation counting, by autoradio-
graphy in laboratory animals and non-invasively in humans with
FDG-PET, radiolabeled 2-deoxyglucose has wide applications in
research and clinical medicine. However, like other radioiso-
topes, it has limited spatiotemporal resolution, with detection
requiring cell populations and typical sampling intervals in excess
of 10min.
Fluorescent analogs of glucose have been used to character-
ize the transport and metabolism of glucose at high resolution
by means of microscopy (Kim et al., 2012). The most popu-
lar analogs are 2-NBDG and 6-NBDG. These compounds are
comprised of a glucose moiety in which a fluorescent nitroben-
zoxydiazoamine (NBD) group replaces the hydroxyl group at
carbon 2 or 6. Both are substrates of GLUT carriers but only
2-NBDG can be phosphorylated by hexokinase. As demonstrated
with 6-NBDG, the bulky hydrophobic NBD group increases the
affinity of binding to GLUTs, but impairs translocation of the
binding site to a larger extent (Barros et al., 2009a), making trans-
port of 6-NBDG by GLUT1 and GLUT3, respectively 100 and
16 times slower than that of glucose (Jakoby et al., 2012). The
low efficiency of translocation provides an important experimen-
tal advantage because it permits the use of confocal microscopy
to monitor uptake in real time over a period of several minutes,
a time window in which agonists can be applied to investigate
acute modulation of glucose transporters (Loaiza et al., 2003;
Porras et al., 2004, 2008). These fluorescent glucose tracers have
also been used to characterize glucose uptake in many other
mammalian cell types including erythrocytes, fibroblasts, smooth
muscle cells, enterocytes, cardiomyocytes, endothelium, lympho-
cytes, pancreatic beta cells, adipocytes, and tumor cells (Barros
et al., 2009a; Kim et al., 2012). Imaging of 2- and 6-NBDG by
multiphoton microscopy has been used to study the transport
and metabolism of glucose in cerebellar and hippocampal slices
(Barros et al., 2009b; Jakoby et al., 2012) and to detect a stimu-
latory effect of neural activity on glucose transport in astrocytes
in the somatosensorial cortex in vivo (Chuquet et al., 2010).
Long-term (>10min) incubation with 2-NBDG followed by a
washout period to remove unphosphorylated 2-NBDG is infor-
mative about glucose consumption, but 2-NBDG cannot be used
to monitor metabolism in real time, because both the phospho-
rylated and unphosphorylated form of the analog are fluorescent,
making it impossible to differentiate between the two. However,
single-cell real-time monitoring of glucose metabolism is now
possible with a genetically-encoded FRET glucose nanosensor.
GLUCOSE METABOLISMMEASURED WITH A
GENETICALLY-ENCODED FRET NANOSENSOR
Ten years ago Wolf Frommer and colleagues introduced the first
FRET glucose nanosensor (Fehr et al., 2003), making an improved
version available in 2008 (Takanaga et al., 2008). Since then, vari-
ous research groups have made fluorescent nanosensors specific
for ATP (Berg et al., 2009; Imamura et al., 2009) and NADH
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(Hung et al., 2011; Zhao et al., 2011) and we have developed
a FRET nanosensor for lactate (San Martín et al., 2013). The
glucose and lactate nanosensors are of the same principle. They
comprise a bacterial protein that binds the analyte, sandwiched
between two fluorescent proteins with overlapping emission and
excitation spectra that undergo FRET. Binding of the analyte to
the bacterial protein induces a conformational change that modi-
fies the distance between the fluorescent protein and/or its relative
orientation, resulting in a change in FRET efficiency which can
be calibrated. Figures 3A,B shows cultured astrocytes express-
ing the glucose nanosensor (FLII12Pglu-700μδ6) and the lactate
nanosensor (Laconic), with the typical cytosolic distribution and
exclusion of nuclei and organelles. In Figure 3C, Laconic has been
targeted to the nucleus and FLII12Pglu-700μδ6 to the cytosol of
HEK293 cells, which permits the use of confocal microscopy to
simultaneously monitor glucose and lactate in the same cell.
All mammalian cells metabolize glucose but they differ in their
handling of lactate. Some cells are lactate exporters, while oth-
ers are lactate importers (Figure 4A). The concentration of a
metabolite, absolute or relative, may be interesting in itself, as
it informs about the balance between production and consump-
tion (Fehr et al., 2003; Bittner et al., 2010, 2011; Takanaga and
Frommer, 2010; Kovacic et al., 2011; Prebil et al., 2011). However,
concentration gives no information about flux. For instance, a
FIGURE 3 | Expression of the glucose and lactate sensors in astrocytes
and HEK293 cells. (A,B) μδ6
and the FRET lactate nanosensor Laconic were expressed in astrocytes
using a custom-made adenoviral vector (Vector Biolabs). Confocal images
correspond to green emission at 535 nm (Venus) as excited with a 488 nm
argon laser. Bar represents 20μm. (C) HEK293 cells were co-transfected
with FLII12Pglu700μδ6 and nuclear-targeted Laconic. The confocal images
show the CFP and mTFP emissions at 480 nm (blue channel) and the
Citrine and Venus emissions at 535 nm (green channel) of a cell expressing
only Laconic (top) and a cell expressing both sensors (bottom). Scale bar is
20μm.
decrease in intracellular glucose may be due to an inhibition of
GLUT-mediated transport (with flux decrease) or a stimulation
of hexokinase (with flux increase). Moreover, the rate of depar-
ture from the steady-state is sensitive to the degree of GLUT
or hexokinase modulation but equally sensitive to resting flux
(Barros et al., 2013), with a fast cell reacting more quickly than
a slow cell to the same degree of stimulation (Barros et al., 2013).
However, by eliminating the contribution of transport with a
GLUT blocker like cytochalasin B, the ambiguity is lifted as the
glucose concentration is forced to decrease with a rate equal to
that of glucose consumption (Figure 4B). This is a protocol that
can be applied repeatedly and which has been validated in astro-
cytes, neurons, muscle cells, fibroblasts, adipocytes, and tumor
cells (Bittner et al., 2010). Most cells express a high affinity iso-
form of hexokinase, with a KD of 50μM, and in the presence
of millimolar extracellular glucose maintain steady-state intra-
cellular glucose levels of 0.5mM or higher, so that hexokinase
runs at Vmax. This explains the linear decrease in glucose con-
centration during the GLUT block. When applied to astrocytes in
culture and in organotypical hippocampal slices, this GLUT-stop
technique revealed that glycolysis is strongly and reversibly stim-
ulated within seconds of exposure to elevated extracellular K+,
a cation that is released by active neurons (Bittner et al., 2011).
Further work showed that K+ activates astrocytic glycolysis by
a sequence of events that begin with plasma membrane depo-
larization, then stimulation of the electrogenic Na+/bicarbonate
co-transporter NBCe1 and intracellular alkalinization (Ruminot
et al., 2011). We also confirmed the stimulatory effect of gluta-
mate on glycolysis that was detected two decades ago by Pellerin
and Magistretti using 2-deoxyglucose (Pellerin and Magistretti,
1994; Pellerin et al., 2007) and showed that the effect of glutamate
on glucose consumption develops over minutes and persists long
after withdrawal of the neurotransmitter (Bittner et al., 2011).
More recently, the same method detected fast changes in the
rate of astrocytic glycolysis in response to variations in extra-
cellular lactate (Sotelo-Hitschfeld et al., 2012), a phenomenon
that may be relevant for the local distribution of fuel in brain
tissue. A general protocol for the use of FRET nanosensors for
metabolites can be found in Hou et al. (2011) and a more
specific practical guide to the use of the glucose sensor for
quantification of glucose consumption is given by Barros et al.
(2013).
LACTATE DYNAMICS MEASUREDWITH A
GENETICALLY-ENCODED FRET NANOSENSOR
LACtate Optical Nano Indicator from Cecs (Laconic) is comprised
of the Escherichia coli protein LldR, the teal fluorescent pro-
tein mTFP and the green fluorescent protein Venus (San Martín
et al., 2013). In bacteria, LldR regulates the transcription of an
operon required for the metabolism of lactate. The binding of
lactate to Laconic is best described by a two-site model, having
a high-affinity component with a KD of 8μM and a low-affinity
component with a KD of 800μM, with each accounting for about
50% of the change in the fluorescence ratio. Expressed in mam-
malian cells, the maximum change in fluorescence ratio is about
40%. The sensor is insensitive to the NADH/NAD+ ratio and
physiological levels of pyruvate and other acidic metabolites. It
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FIGURE 4 | Estimation of metabolic fluxes with transport-stop protocols.
(A) Whereas most mammalian cells are glucose importers, some cells export
lactate and some import lactate. (B) A single astrocyte incubated in 2mM
extracellular glucose maintained an intracellular glucose of approx. 0.6mM.
Interruption of the steady state by blocking the glucose transporter GLUT1
with 20μM cytochalasin B caused a decrease in the cytosolic concentration
of glucose at a rate of −7.2μM/s. (C) A HEK293 was incubated in 25mM
glucose. Blockage of the MCT with 50μM phloretin caused an accumulation
of intracellular lactate with an initial rate of 2.3μM/s. (D) Same cell as in
(B) but incubated in 1mM lactate in the absence of glucose. Blockage of the
MCT with 50μM phloretin caused a depletion of intracellular lactate with an
initial rate of −0.5μM/s.
shows little sensitivity to pH changes in the physiological range of
the mammalian cytosol, (pH 7.0–7.4) (San Martín et al., 2013).
In mammalian cells, lactate is transported across the plasma
membrane by the monocarboxylate transporter (MCT). Use of
the lactate sensor to estimate the flux of lactate in HEK293 cells
with an MCT-stop protocol is illustrated in Figures 4C,D. In
the presence of glucose, exposure of cells to the MCT inhibitor
phloretin caused an increase in the concentration of intracel-
lular lactate, showing that the cell was exporting lactate. The
rate of lactate accumulation reached a maximum immediately
after MCT blockage and reflects the magnitude of the lactate
flux in the steady-state, decreasing later because feedback inhibi-
tion of glycolysis by lactate (Sotelo-Hitschfeld et al., 2012) and/or
delayed depletion of intracellular glucose caused by phloretin,
also a GLUT blocker. Similar results have been obtained with the
non-permeant MCT blocker pCMBS and with the more specific
MCT blocker AR-C155858 (San Martín et al., 2013). Inhibition
of the MCT in the same HEK293 cells incubated in the presence
of lactate but with glucose absent, caused a decrease in intracellu-
lar lactate, showing that the cell was importing lactate. This type
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of protocol may be used to address the question of intercellular
lactate exchange, which is of great interest for neuroenergetics
(Pellerin et al., 2007; Barros and Deitmer, 2010; Allaman et al.,
2011; Wyss et al., 2011) and in cancer research (Yeluri et al., 2009;
Tennant et al., 2010).
Normal cells oxidize most of the glucose they take up, export-
ing small amounts of lactate or importing lactate. Cancer cells
often have deficient mitochondria and a strong glycolytic flux,
exporting much more lactate than normal cells. This phe-
nomenon is known as the Warburg effect and may be important
for cancer progression (Vander Heiden et al., 2009). The Warburg
effect can be detected non-invasively in humans by FGD-PET for
the purposes of cancer diagnosis and staging. For basic research,
the Warburg effect may be observed in cell populations or tissue
FIGURE 5 | Use of the lactate sensor to detect the Warburg effect.
An astrocyte (A) and a T98G glioma cell (B) expressing Laconic were
sequentially exposed to 5mM sodium azide, 50μM phloretin and 500μM
pCMBS. The straight lines represent initial slopes of lactate accumulation
fitted by linear regression within the same range of ratio values. (C)
Correlation plot between the rates of lactate accumulation ( ratio/min) in
sodium azide and in pCMBS. Symbols represent single astrocytes (white),
HEK293 cells (gray) or T98G cells (black). (D) The Warburg Index was
estimated as the ratio between the rates of lactate production with pCMBS
and lactate accumulation with azide, and was used to color the silhouette of
each cell according to the 16-color look up table. The inset shows an isolated
cell that was located about 100μm from the cluster. The bar graph
summarizes data from 3 experiments in each cell type. Scale bars are 20μm.
∗p < 0.05 between every cell type. Modified from San Martín et al. (2013).
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explants by monitoring the rate of oxygen consumption. Taking
advantage of the resolution afforded by the FRET lactate sen-
sor, we devised a protocol that provides a quantitative estimate
of the Warburg effect in single cells (San Martín et al., 2013).
Cells are first exposed to sodium azide, a reversible inhibitor
of oxidative phosphorylation. Normal cells respond to mito-
chondrial poisoning with an acute stimulation of glycolysis
(Bittner et al., 2010), causing a rapid accumulation of intra-
cellular lactate (Figure 5A). This response is weaker in cancer
cells (Figure 5B). After intracellular lactate returns to baseline
levels, cells are exposed to an MCT blocker in order to mea-
sure the rate of lactate production, which is higher in cancer
cells. The difference between astrocytes and T98G glioma cells
becomes evident when both rates are plotted for each cell as
shown in Figure 5C. The difference can be quantified by comput-
ing the ratio between the rate of lactate production and the rate
of lactate accumulation with sodium azide, termed the Warburg
Index (WI), as illustrated in Figure 5D. Astrocytes had WI val-
ues of <0.1 whereas T98G glioma cells had WI values of >2,
with intermediate values observed for the non-transformed cell
line HEK293. Tumors are complex systems in which cancer cells
of differing degrees of malignancy co-exist with non-cancerous
cells of several lineages. The single-cell resolution provided by
genetically-encoded FRET nanosensors together with multipho-
ton microscopy may help to investigate metabolic exchanges
within tumors.
CONCLUSION AND PERSPECTIVES
Genetically-encoded sensors permit single cell estimation of
metabolite concentration with sufficient temporal resolution to
detect physiological fluctuations. In the case of glucose and lac-
tate, inhibitor-stop protocols are available that measure rates of
usage and production. Together with improved expression sys-
tems and imaging in tissue slices and in vivo, these tools open the
way to a characterization of energy metabolism in identified cells
in healthy and diseased tissue.
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